Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

5Total

Not Applicable (4)

P 4 (1)

Trial Status

Completed3

Recruiting1

Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (5)

Showing 5 of 5 trials

NCT07369232Not ApplicableCompleted

Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT)

NCT07089381Not ApplicableRecruiting

Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.

NCT05944458Phase 4Completed

Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients

NCT03063372Not ApplicableActive Not RecruitingPrimary

Pomegranate Supplementation and Well-Being Among Medical Students and Residents

NCT01684332Not ApplicableCompleted

Postprandial Response to Different Jams

Showing all 5 trials

Antioxidant